JHGRX quote
26.57unchanged unch
Previous Close26.57CategoryHealth
Net Assets80.20 MilDividend Yield0.00%
Morningstar ratings:Minimum Initial Purchase2,500
RiskAverage1 Year Return-8.38%
RatingRating: 2 out of 53 Year Return-6.11%
ReturnBelow Average5 Year Return-0.53%
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth13.48%33.43%34.67%44.26%21.63%2.70%
Value$11,348$13,343$13,467$14,426$12,163$10,270
Last NAV update 10/02/2009 5:05 PM ET   Financial data in U.S. dollars

Your latest quotes:  PRINX, JHGRX, MAS, QTWW, CSTR, SUPG

Overview
The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in equities of U.S. and foreign health sciences companies. It may invest more than 5% of assets in securities of individual companies. The fund is nondiversified.In abnormal circumstances, the fund may temporarily invest more than 20% of its assets in investment-grade short-term securities.
More information for JHGRX
Fees and expenses
Front load5.00%
Deferred load0.00%
Expense Ratio1.67%
Top holdings for JHGRX
Company Name% Net Assets
Cephalon, Inc.5.83%
Johnson & Johnson5.57%
Pfizer Inc.5.47%
Medco Health Solutions, Inc.5.35%
Abbott Laboratories5.08%
More top holdings for JHGRX
Additional Fund Information
Inception date10/01/1991
ManagerMindy Perry
Manager start date04/02/2008
advertisement
Market update 6:08pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news
advertisement


Page generated 9:08 PM Eastern Time